- Medical School - Johns Hopkins University (1989-1993)
- Internship - Johns Hopkins School of Medicine (1993-1994), General Surgery
- Residency - Johns Hopkins School of Medicine (1994-1995), General Surgery
- Residency - Johns Hopkins School of Medicine (1995-1998), Urology
Jeffrey Cadeddu, M.D.
- Ralph C. Smith, M.D., Distinguished Chair in Minimally Invasive Urologic Surgery
- Kidney Cancer
- Genitourinary Surgery
Jeffrey Cadeddu, M.D., is one of Texas’ leading urologists in the surgical treatment of prostate and kidney disorders. As Director of the UT Southwestern Clinical Center for Minimally Invasive Treatment of Urologic Cancer, he has performed more than 500 robotic/laparoscopic procedures on the prostate and introduced a number of firsts in the minimally invasive surgical treatment of kidney cancer and kidney disease.
His training and extensive experience with kidney cancers in particular allow him to offer patients the full gamut of options in managing the disease without losing the kidney. Those options include ablation, an outpatient procedure in which the tumor is destroyed with a heated probe, rather than removed surgically. Dr. Cadeddu was the first in Texas to perform the procedure. He also has the most experience in North Texas with laparoscopic and robotic partial nephrectomy to remove kidney cancers.
Along with an active clinical practice focused on minimally invasive procedures, Dr. Cadeddu maintains a robust research program aimed at developing new technologies and techniques that will make kidney surgery even less invasive while also maximizing kidney function better than what has traditionally been done.
Dr. Cadeddu joined the faculty of UT Southwestern Medical Center, where he is a Professor of Urology and Radiology, in 1999 after receiving his initial medical training and completing residencies in urology and surgery at Johns Hopkins School of Medicine in Baltimore.
As an expert in the treatment of kidney and prostate diseases, Dr. Cadeddu regularly lectures and educates other medical professionals on the latest developments in managing urologic conditions. In 2007, he received the Gold Cystoscope Award from the American Urological Association for his contributions to advances in kidney cancer treatment and the training of numerous academic urologists.
In 2018, he was included in D Magazine's Best Doctors list and was named a Texas Monthly Super Doctor.
Meet Dr. Cadeddu
Dallas Urologist and Pioneering Laparoscopic Surgeon
When Jeffrey Cadeddu, M.D., was recruited to UT Southwestern Medical Center in 1999, he came because he thought it would be a good place to practice medicine and offer opportunities to do groundbreaking work in the field of urology. He hasn’t been disappointed, nor have his patients, who have gained access to leading-edge procedures pioneered by Dr. Cadeddu.
"We’re not resting on our laurels. We’re continuing to develop new technologies and new techniques. My goal is to continue to push the envelope.”
A recognized expert in laparoscopic and robotic surgery, Dr. Cadeddu was the first surgeon in the U.S. to successfully remove a patient’s kidney through the belly button, reducing both scarring and recovery time; the first in North Texas to repair a malfunctioning kidney laparoscopically through the belly button; the first in North Texas to perform laparoscopic prostatectomy for prostate cancer; and the first in Texas to destroy kidney tumors by burning them – known as radiofrequency ablation – rather than removing them through surgery.
“I do a lot of research in novel technologies for treating patients with kidney problems and kidney cancer,” he says.
With 20 years’ experience as a urologist, Dr. Cadeddu treats both kidney and prostate conditions. “The kidney and the prostate are the two most complex, challenging operations we do, but both are particularly amenable to minimally invasive techniques,” he says. “With the kidney, the difference between minimally invasive and regular surgery is three to four less days in the hospital and a month to a month-and-a-half quicker recovery.”
Developing groundbreaking techniques and producing good outcomes and quicker recoveries keep Dr. Cadeddu at the forefront of his field. But, he says, it’s grateful patients who ultimately are the source of his greatest satisfaction.
- American Urological Association
- Endourological Society
- Society for Urologic Oncology
- Texas Super Doctors, Urology 2012
- Gold Cystoscope Award 2007, For Significant Contributions to the Field of Urology within 10 Years of Residency
- Ralph C. Smith, MD, Distinguished Chair in Minimally Invasive Urologic Surgery 2006
- Alpha Omega National Medical Honor Society 1998, The Johns Hopkins University School of Medicine
- Best Doctors in Dallas, 2007 - 2012
Urologic laparoendoscopic single-site surgery (LESS): multiinstitutional analysis of risk factors for conversions and postoperative complications
Autorino R, Kaouk JH, Yakoubi R, et al, and Cadeddu JA. 2012 187 1989
Durable oncologic outcomes following radiofrequency ablation (RFA): experience from treating 243 small renal masses over 7.5 years
Tracy CR, Raman JD, Donnally C, Trimmer CK, and Cadeddu, JA Cancer 2010 ePub
Characterization of renal ischemia using DLP hyperspectral imaging: a comparison of artery-only occlusion (AO) versus artery and vein occlusion (AV)
Tracy, CR, Terrell JD, Francis RP, Wehner EF, Smith J, Lirotja M, Hawkins DL, Pearle MS, Cadeddu JA J Endourol 2010 24 321
single incisions versus conventional laparoscopic nephrectomy: a comparison of perioperative outcomes and short-term measures of convalescence.
Raman JD, Bagrodia A, and Cadeddu JA Eur Urol 2009 55 1198
Radiofrequency ablation of small renal cortical tumors in healthy adults: renal function preservation and intermediate oncologic outcome
Stern JM, Gupta A, Raman JD, Cost N, Lucas S, Lotan Y, Raj GV, and Cadeddu JA BJUI 2009 104 786
Novel magnetically guided intra-abdominal camera to facilitate laparoendoscopic single site surgery: initial human experience
Cadeddu, JA, Fernandez R, Desai Mi, Bergs R, Tang SJ, Rao P, Desai Ma, and Scott DJ Surg Endoscopy 2009 23 1894
Magnetic resonance spectroscopy predicts the histologic assessment of radiofrequency ablated renal tissue
Stern JM, Merritt ME, Zeltser I, Raman JD, Cadeddu JA Eur Urol 2009 55 433
Optical reflectance spectroscopy to differentiate benign from malignant renal tumors at surgery
Bensalah K, Peswani D, Tuncel A, Raman JD, Zeltser I, Liu H, and Cadeddu JA Urology 2009 73 178
Does topical hemostatic agent have an adverse effect on prostatic neurovaxcular bundle function?
Zeltser IS, Dugi D, Gupta A, Park S, Kabbani W, and Cadeddu JA BJUI 2008 102 1005
The new economics of radical prostatectomy: cost-comparison of open, laparoscopic, and robot-assisted techniques
Lotan Y, Cadeddu JA, and Gettman MT J Urol 2004 172 1731
Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy
Cadeddu, JA, Partin AW, DeWeese TL, and Walsh PC J Urol 1998 159 173
- Urologic laparoendoscopic single-site surgery (LESS): multiinstitutional analysis of risk factors for conversions and postoperative complications
- Surgical Education
- Prostate Cancer
- Laparoscopic Techniques
- Kidney Cancer
- Kidney Cancer
- Genitourinary Surgery
- Genitourinary Cancer
- Prostate Cancer
- Testicular Cancer